Distribution of different ingredients at the same IDDSI level (Percentage and frequency) and statistical significance analysis (Chi-square test)^b'*'. by Muxi Chen (9294270)

Subjects:

MIP receptor expression in <i>N. lugens</i>: relative quantification of <i>mipr</i> transcript levels in different developmental stages (A) and tissues (B) of <i>N. lugens.</i> by Yi-Jie Zhang (713506)

Relative quantification of <i>mip</i> transcript levels in different developmental stages (A) and tissues (B) of brown planthopper. by Yi-Jie Zhang (713506)

Some examples of selected Chinese characters. by Weijia Zhu (65481)

“…Our model shows clear enhancements in structural accuracy (SSIM improved to 0.91), pixel-level fidelity (RMSE reduced to 2.68), perceptual quality aligned with human vision (LPIPS reduced to 0.07), and stylistic realism (FID decreased to 13.87). …”

Changes in the distribution of average sleep duration. by Hea Ree Park (10769827)

Subjects:

Changes in symptoms of insomnia and excessive daytime sleepiness during the COVID-19 pandemic by age. by Hea Ree Park (10769827)

Subjects:

Changes in sleep patterns before versus during the COVID-19 pandemic by age. by Hea Ree Park (10769827)

Subjects:

Sociodemographic characteristics. by Hea Ree Park (10769827)

Subjects:

Changes in sleep habits and sleep-related symptoms. by Hea Ree Park (10769827)

Subjects:

Regression analysis of sleep habits and sleep-related symptoms associated with pandemic status. by Hea Ree Park (10769827)

Subjects:

Study flow chart. by Hea Ree Park (10769827)

Subjects:

Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis by Tiantian Wang (1688881)

“…We found that FHND5032 significantly upregulated miR-124 expression in macrophages, surpassing the clinical-stage comparator ABX464 in vitro and in vivo. …”

Green Hydrogen Economy: Scenarios versus Technologies by Hua Fan (495346)

“…Our findings reveal that operational scenarios can reduce LCOH more significantly than technological improvements alone. …”

Receptivity of virgin and mated females after seminal fluid protein candidate genes were knocked down by dsRNA injections, scored as the percentage of females that copulated within... by Yi-Jie Zhang (713506)

Changes in the neutrophil count. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

Changes in the platelet count. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

Changes in the white blood cell count. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

Changes in the hemoglobin. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

WBC and ANC on day 7 post-chemotherapy. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

General clinical data of 88 patients with NPC. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”